Multi-site pre-therapeutic biopsies demonstrate genetic heterogeneity in patients with newly diagnosed diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Multi-site pre-therapeutic biopsies demonstrate genetic heterogeneity in patients with newly diagnosed diffuse large B-cell lymphoma

Published:2023-06-16 Issue:9 Volume:64 Page:1527-1535
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Hersby Ditte Stampe¹^ORCID,Schejbel Lone²,Breinholt Marie Fredslund²,Høgdall Estrid²,Nørgaard Peter³,Dencker Ditte⁴,Nielsen Torsten Holm¹⁵,Pedersen Lars Møller⁶⁷,Gang Anne Ortved¹⁷

Affiliation:

1. Department of Hematology, Rigshospitalet, Copenhagen, Denmark

2. Department of Pathology, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark

3. Department of Pathology, Hvidovre Hospitalet, Hvidovre, Denmark

4. Department of Radiology, Rigshospitalet, Copenhagen, Denmark

5. Danish Medicines Agency, Copenhagen, Denmark

6. Department of Hematology, Zealand Hospital, Roskilde, Denmark

7. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2220454

Reference40 articles.

1. Management of relapsed/refractory DLBCL

2. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

3. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

4. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

5. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Tumor DNA as a Complementary Prognostic Biomarker during CAR-T Therapy in B-Cell Non-Hodgkin Lymphomas;Cancers;2024-05-15

2. Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice;Leukemia & Lymphoma;2024-02-10

3. Atypical presentation of γ/δ mycosis fungoides with an unusual phenotype and SOCS1 mutation;Open Life Sciences;2024-01-01